Dacarba

Dacarba GmbH is a specialized pharmaceutical company based in Hamburg, Germany, and operates as a wholly-owned subsidiary of medac GmbH. The company is dedicated to the field of oncology, with a specific focus on the development and distribution of treatments for malignant melanoma and other solid tumors. Its primary product is dacarbazine, an alkylating agent that serves as a cornerstone in chemotherapy regimens for metastatic melanoma and Hodgkin's lymphoma. By leveraging the extensive regulatory and manufacturing expertise of the medac group, Dacarba ensures the global availability of essential oncology medicines. The company plays a critical role in medac's strategy to provide specialized clinical solutions for life-threatening diseases. Its operations are tightly integrated with the parent company's infrastructure to maintain high standards in production and clinical support.